(by Andegna.com) Diabetes, one of the world’s most rapidly growing non-communicable diseases, seems to be arrested after researchers at Norwegian University of Science and Technology (NTNU) in Trondheim and Oxford University said they have discovered an appetite-reducing hormone, which they hope can be used in the fight against type 2 diabetes.
The sensational discovery came about because of the after effects of the operations of morbidly obese people, TV 2 writes, reports NorwayToday, which many of the patients experienced a decline of diabetes after operations, and scientists have now proven that this effect is caused by the appetite-reducing hormone PYY.
However the drug is not yet tested on humans, the researchers conducted experiments on rats, and these experiments have shown that the medicine that stimulates the production of Peptide YY (PYY), can stop type 2 diabetes.
“The discovery is quite revolutionary, because the number of people who have type 2 diabetes is believed to reach 600 million worldwide in 15 year time,” Magnus Kringstadbukta Olsen, PhD student at the Institute of Cancer Research and Molecular Medicine at NTNU, says.
In 2014; 422 million people worldwide had diabetes, according to the research site Gemini.